|Articles|November 1, 2010
- BioPharm International-11-01-2010
- Volume 23
- Issue 11
BioPharm International, November 2010 Issue (PDF)
Making Chemically Defined Media Work
Advertisement
Articles in this issue
about 15 years ago
Time to Revisit Supplier Quality Managementabout 15 years ago
Biosimilars Regulation in the US: The Challengesabout 15 years ago
Managing Raw Materials in the QbD Paradigm, Part 1: Understanding Risksabout 15 years ago
Biotech Manufacturers Anticipate CER Challengesabout 15 years ago
A Dizzying CourseNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
